IMPORTANT SAFETY INFORMATION
Do not take AZILECT® (rasagiline tablets) if you are taking meperidine as it could result in a serious reaction such as coma or death. Also, do not take AZILECT with tramadol, methadone, propoxyphene, dextromethorphan, St. John’s wort, or cyclobenzaprine. You also should not take AZILECT with other monoamine oxidase inhibitors (MAOIs), as it could result in an unsafe rise in blood pressure. Read More Important Safety Information

Program Rules - Patient Eligibility and Terms and Conditions


Valid only for qualified patients with a valid prescription for AZILECT® (rasagiline tablets). No substitutions are permitted. This card is valid only for those with private insurance or for cash-paying patients. This card is not valid for prescriptions paid for in part or in full by any state or federally funded program, including but not limited to Medicare or Medicaid, Medigap, VA, DOD, Tricare®, or the Puerto Rico Government Health Insurance Plan, or by private health insurance plans or programs that reimburse patients for the entire costs of their prescription drugs. This card is not valid for patients who are Medicare eligible and are enrolled in an employer-sponsored health plan or prescription drug benefit program for retirees (i.e., patients who are eligible for Medicare Part D but receive a prescription drug benefit through a former employer). Patient discount with this card is valid to reduce the co-pay to $5, with a maximum benefit of $110 per month. For example, if the total co-pay is $115 or less, the patient will pay no more than $5 per month. If the co-pay is more than $115, the patient’s co-pay will be reduced by a maximum amount of $110 per month. Offer expires December 31, 2016.

Your acceptance of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or other third-party payer, and you agree to report acceptance of this offer to your health insurer, health plan, or third-party payer as may be required. Offer limited to one card per person and may not be used with any other discount, coupon, or offer. Offer is not transferable. It is illegal to sell, purchase, trade, or counterfeit this card. This card is not health insurance. This card is the property of Teva Neuroscience, Inc., and must be returned upon request. Offer is valid only in the United States or the Commonwealth of Puerto Rico at participating pharmacies. Void in any state where prohibited by law, taxed, or restricted. Teva Neuroscience, Inc., reserves the right to change, rescind, revoke, or discontinue this offer at any time without notice. By participating in this program, you, the patient, certify that (a) you have read the above terms; (b) you are not reimbursed, nor will you submit a claim for reimbursement, nor will you seek to have any portion of this prescription counted toward your out-of-pocket costs (e.g., TROOP) under any federal, state, or private programs for this or other prescriptions for AZILECT to which this offer will apply; and (c) you will otherwise comply with the terms above.

INDICATION
AZILECT® (rasagiline tablets) is indicated for the treatment of Parkinson’s disease (PD).

IMPORTANT SAFETY INFORMATION
  • Do not take AZILECT if you are taking meperidine as it could result in a serious reaction such as coma or death. Also, do not take AZILECT with tramadol, methadone, propoxyphene, dextromethorphan, St. John’s wort, or cyclobenzaprine. You also should not take AZILECT with other monoamine oxidase inhibitors (MAOIs), as it could result in an unsafe rise in blood pressure
  • Increases in blood pressure may occur during treatment with AZILECT. Inform your physician if you have a history of high blood pressure. Possible symptoms of an unsafe rise in blood pressure include severe headache, blurred vision, difficulty thinking, seizure, chest pain, and nausea/vomiting. It is important that if you experience these symptoms that you speak with your doctor or seek medical attention. When AZILECT is taken at recommended doses, restriction of foods and beverages containing a substance called tyramine is ordinarily not required. However, it is recommended that you avoid foods containing high amounts of tyramine such as aged cheeses as some patients may have an increased sensitivity that could lead to an unsafe rise in blood pressure as described above
  • Inform your physician if you are taking, or planning to take, any prescription or over-the-counter drugs, especially antidepressants and ciprofloxacin. The combination of MAO-B inhibitors such as AZILECT and antidepressants has resulted in a serious and sometimes fatal condition called serotonin syndrome
  • If you experience episodes of falling asleep or drowsiness during activities of daily living, do not drive and exercise caution until you contact your physician
  • If you have moderate to severe liver disease, you should not take AZILECT. You should not exceed a dose of 0.5 mg per day of AZILECT if you have mild liver disease or are taking ciprofloxacin. Patients should not exceed a dose of 1 mg per day of AZILECT because of the risk of increased blood pressure
  • All PD patients should be monitored for a change in blood pressure, uncontrolled movements (dyskinesia), hallucinations, impulse control, confusion, and melanoma (skin cancer). A possible rise in body temperature may occur upon stopping AZILECT
  • The most common side effects seen with AZILECT alone are flu syndrome, joint pain, depression, and indigestion; when taken with a dopamine agonist are swelling of the legs, fall, joint pain, cough, and inability to sleep; and when taken with levodopa are uncontrolled movements (dyskinesia), accidental injury, weight loss, low blood pressure when standing, vomiting, anorexia, joint pain, abdominal pain, nausea, constipation, dry mouth, rash, abnormal dreams, fall, and swelling of tendons
  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
  • Please see full Prescribing Information.